TRICYCLIC 2-PYRIMIDONE COMPOUNDS USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:EP1474424A1
公开(公告)日:2004-11-10
US6844340B2
申请人:——
公开号:US6844340B2
公开(公告)日:2005-01-18
US7186830B2
申请人:——
公开号:US7186830B2
公开(公告)日:2007-03-06
[EN] TRICYCLIC 2-PYRIMIDONE COMPOUNDS USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] COMPOSES 2-PYRIMIDONES TRICYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE LA TRANSCRIPTASE INVERSE DU VIH
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2003062238A1
公开(公告)日:2003-07-31
The present invention relates to tricyclic 2-pyrimidone compounds of formula (I), or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.